Gene: BRME1
Official Full Name: break repair meiotic recombinase recruitment factor 1provided by HGNC
Gene Summary: Predicted to enable damaged DNA binding activity. Predicted to be involved in meiosis I; protein localization to site of double-strand break; and spermatogenesis. Predicted to be located in chromosome. Predicted to be active in site of double-strand break. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19371 | BRME1 Knockout cell line (HeLa) | Human | BRME1 | 1:3~1:6 | Negative | Online Inquiry |
KO19372 | BRME1 Knockout cell line (HCT 116) | Human | BRME1 | 1:2~1:4 | Negative | Online Inquiry |
KO19373 | BRME1 Knockout cell line (HEK293) | Human | BRME1 | 1:3~1:6 | Negative | Online Inquiry |
BRME1 Gene Knockout Cell Lines are specially engineered cell lines where the BRME1 gene has been deliberately disrupted, enabling researchers to investigate the gene's function in biological processes and disease pathways. This innovative product is generated using cutting-edge CRISPR-Cas9 technology, which facilitates precise genetic modifications. By knocking out the BRME1 gene, researchers can elucidate its role in cellular mechanisms, such as proliferation, differentiation, and stress response.
The primary function of BRME1 Gene Knockout Cell Lines is to serve as a valuable tool for functional genomics studies. The absence of the BRME1 gene allows for the observation of phenotypic changes, helping scientists identify compensatory pathways and determine the gene’s contributions to various cellular functions. In clinical research, these cell lines can be instrumental in disease modeling, particularly in understanding cancer and other diseases where BRME1 may play a critical role.
The scientific importance of these knockout cell lines cannot be overstated; they provide a robust system for drug discovery, biomarker identification, and therapeutic target validation. By offering a controlled environment to study the effects of BRME1 loss-of-function, these cell lines can lead to novel insights in molecular biology and therapeutic interventions.
What sets BRME1 Gene Knockout Cell Lines apart from alternative cell line models is their specificity and the precision of the gene knockout achieved through advanced genome editing techniques. While other models may rely on transient silencing techniques or incomplete knockdowns, BRME1 knockout cell lines provide a stable and reliable platform for long-term studies.
These unique features position the BRME1 Gene Knockout Cell Lines as indispensable tools for researchers and clinicians aiming to deepen their understanding of gene function and its implications in health and disease. The opportunity to conduct precise, reproducible, and relevant research is invaluable in an era where personalized medicine is gaining ground.
Our company, a leader in the development of innovative biological products, is committed to delivering high-quality gene knockout models that meet the rigorous standards of contemporary scientific research. By empowering researchers with specialized tools like the BRME1 Gene Knockout Cell Lines, we aim to facilitate groundbreaking discoveries that lead to improved healthcare outcomes.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.